It’s just so often that we are seeing patients that are presenting at advanced stages, where chances for a cure are very slim ...

New research reveals 5 ways exercise enhances cancer treatment effectiveness, offering hope to patients with chronic ...

PGV001, a personalized cancer vaccine, induced immune responses across various cancer types like breast and urothelial cancer ...

The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

Panelists discuss how the five-year prognosis for advanced non-small cell lung cancer (NSCLC) has improved with PD-1 inhibitors, showing promising overall survival (OS) and progression-free survival ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

A homeless woman with lung cancer is sleeping on a makeshift bed in her friend's living room because she says the ...

Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million ...

Learn more about supplements for lung health, including vitamins, minerals, and herbs that support breathing, reduce ...

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

An exploratory analysis shows a reduction in extrathoracic metastases and prolonged time to progression or death due to any metastases with durvalumab vs placebo.

BeiGene is ending development of its experimental lung-cancer treatment ociperlimab following the failure of a late-stage study. BeiGene on Thursday said it is stopping a Phase 3 trial of ociperlimab ...